FPN1, Targeted By Mir-17-5p, Regulates Cellular Iron Homeostasis Via activating Nrf2/Mir-17-5p/FPN1 Axis in Preclinical Model of Multiple Myeloma

被引：0
|
作者：
Kong, Yuanyuan [1 ]
Chang, Shuaikang [1 ]
Hu, Liangning [1 ]
Chen, Gege [1 ]
Tao, Yi [1 ]
Wang, Yingcong [1 ]
Yu, Dandan [1 ]
Lu, Kang [1 ]
Xie, Yongsheng [1 ]
Bu, Wenxuan [1 ]
Shi, Jumei [1 ]
机构：
[1] Tongji Univ, Shanghai Peoples Hosp 10, Dept Hematol, Sch Med, Shanghai, Peoples R China
来源：
BLOOD | 2018年 / 132卷
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1182/blood-2018-99-112230
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5616
引用
收藏
页数：3
相关论文
共 50 条
  • [41] miR-17-5p affects porcine granulosa cell growth and oestradiol synthesis by targeting E2F1 gene
    Zhang, Shuna
    Wang, Ling
    Wang, Lei
    Chen, Yaru
    Li, Fenge
    REPRODUCTION IN DOMESTIC ANIMALS, 2019, 54 (11) : 1459 - 1469
  • [42] Diabetic and nondiabetic BMSC-derived exosomes affect bone regeneration via regulating miR-17-5p/SMAD7 axis
    Li, Zechuan
    Zhang, Bing
    Shang, Jiaming
    Wang, Yanan
    Jia, Linglu
    She, Xiao
    Xu, Xin
    Zhang, Dongjiao
    Guo, Jing
    Zhang, Fan
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 125
  • [43] PEITC promotes neurite growth in primary sensory neurons via the miR-17-5p/STAT3/GAP-43 axis
    Wang, Zhijie
    Yuan, Wenqi
    Li, Bo
    Chen, Xueming
    Zhang, Yanjun
    Chen, Chuanjie
    Yu, Mei
    Xiug, Yucai
    Lig, Wenhua
    Cao, Jiangang
    Wang, Xin
    Tao, Wen
    Guo, Xiaoling
    Feng, Shiqing
    Wang, Tianyi
    JOURNAL OF DRUG TARGETING, 2019, 27 (01) : 82 - 93
  • [44] Pseudogene INTS6P1 regulates its cognate gene INTS6 through competitive binding of miR-17-5p in hepatocellular carcinoma
    Peng, Haoran
    Ishida, Masaharu
    Li, Ling
    Saito, Atsushi
    Kamiya, Atsushi
    Hamilton, James P.
    Fu, Rongdang
    Olaru, Alexandru V.
    An, Fangmei
    Popescu, Irinel
    Iacob, Razvan
    Dima, Simona
    Alexandrescu, Sorin T.
    Grigorie, Razvan
    Nastase, Anca
    Berindan-Neagoe, Ioana
    Tomuleasa, Ciprian
    Graur, Florin
    Zaharia, Florin
    Torbenson, Michael S.
    Mezey, Esteban
    Lu, Minqiang
    Selaru, Florin M.
    ONCOTARGET, 2015, 6 (08) : 5666 - 5677
  • [45] Inhibiting of circ-TLK1 inhibits the progression of glioma through down-regulating PANX1 via targeting miR-17-5p
    Wang, Zizhang
    Chen, Xu
    Liang, Qinlong
    An, Yuan
    Wei, Meng
    Shi, Wei
    JOURNAL OF MOLECULAR HISTOLOGY, 2021, 52 (05) : 1007 - 1020
  • [46] Berberine suppresses bladder cancer cell proliferation by inhibiting JAK1-STAT3 signaling via upregulation of miR-17-5p
    Xia, Yangyang
    Chen, Shouzhen
    Cui, Jianfeng
    Wang, Yong
    Liu, Xiaochen
    Shen, Yangli
    Gong, Li
    Jiang, Xuewen
    Wang, Wenfu
    Zhu, Yaofeng
    Sun, Shuna
    Li, Jiangxia
    Zou, Yongxin
    Shi, Benkang
    BIOCHEMICAL PHARMACOLOGY, 2021, 188
  • [47] miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer
    Jie Li
    Yuanhui Lai
    Jieyi Ma
    Yue Liu
    Jiong Bi
    Longjuan Zhang
    Lianzhou Chen
    Chen Yao
    Weiming Lv
    Guangqi Chang
    Shenming Wang
    Mao Ouyang
    Wenjian Wang
    BMC Cancer, 17
  • [48] Neferine inhibits the progression of diabetic nephropathy by modulating the miR-17-5p/nuclear factor E2-related factor 2 axis
    HUANG Hongmei
    YANG Maojun
    LI Ting
    WANG Dandan
    LI Ying
    TANG Xiaochi
    YUAN Lu
    GU Shi
    XU Yong
    Journal of Traditional Chinese Medicine, 2024, 44 (01) : 44 - 53
  • [49] Neferine inhibits the progression of diabetic nephropathy by modulating the miR-17-5p/nuclear factor E2-related factor 2 axis
    Huang, Hongmei
    Yang, Maojun
    Li, Ting
    Wang, Dandan
    Li, Ying
    Tang, Xiaochi
    Yuan, Lu
    Gu, Shi
    Xu, Yong
    JOURNAL OF TRADITIONAL CHINESE MEDICINE, 2024, 44 (01) : 44 - 53
  • [50] LncRNA H19 Inhibits Keratinocyte Cell Proliferation and Migration by Targeting miR-17-5p/RUNX1 Axis in Chronic Wounds
    Ji, Wei
    Zhang, Qian
    Sun, Zhibo
    Cheng, Yanyang
    JOURNAL OF BURN CARE & RESEARCH, 2024, 45 (02): : 366 - 372
12345